Ameritas Investment Partners, Inc. - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$272,623
+8.7%
9,254
+20.3%
0.01%
+22.2%
Q2 2023$250,880
+10.8%
7,691
+19.5%
0.01%0.0%
Q1 2023$226,518
-16.6%
6,4370.0%0.01%
-18.2%
Q4 2022$271,641
-12.7%
6,4370.0%0.01%
-21.4%
Q3 2022$311,000
+29.0%
6,437
+4.8%
0.01%
+40.0%
Q2 2022$241,000
+6.6%
6,1450.0%0.01%
+25.0%
Q1 2022$226,000
-19.3%
6,1450.0%0.01%
-11.1%
Q4 2021$280,000
+27.3%
6,1450.0%0.01%
+12.5%
Q3 2021$220,000
+96.4%
6,145
+8.7%
0.01%
+100.0%
Q2 2021$112,000
-15.2%
5,6550.0%0.00%
-20.0%
Q1 2021$132,000
+11.9%
5,6550.0%0.01%0.0%
Q4 2020$118,000
-3.3%
5,6550.0%0.01%
-16.7%
Q3 2020$122,000
+10.9%
5,655
+20.7%
0.01%
+20.0%
Q2 2020$110,000
+100.0%
4,6850.0%0.01%
+66.7%
Q1 2020$55,000
+10.0%
4,6850.0%0.00%
+50.0%
Q4 2019$50,000
-5.7%
4,6850.0%0.00%0.0%
Q3 2019$53,0000.0%4,6850.0%0.00%0.0%
Q2 2019$53,000
+76.7%
4,685
+28.5%
0.00%
+100.0%
Q1 2019$30,000
+30.4%
3,6470.0%0.00%0.0%
Q4 2018$23,000
-36.1%
3,6470.0%0.00%
-50.0%
Q3 2018$36,000
+20.0%
3,6470.0%0.00%
+100.0%
Q2 2018$30,000
+15.4%
3,6470.0%0.00%0.0%
Q1 2018$26,000
-13.3%
3,6470.0%0.00%0.0%
Q4 2017$30,000
-44.4%
3,6470.0%0.00%
-66.7%
Q3 2017$54,000
+22.7%
3,6470.0%0.00%
+50.0%
Q2 2017$44,000
+22.2%
3,647
+28.6%
0.00%0.0%
Q1 2017$36,0002,8360.00%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders